Immune response to influenza vaccine in children with inflammatory bowel disease.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMC 3805272)

Published in Am J Gastroenterol on January 27, 2009

Authors

Ying Lu1, Denise L Jacobson, Lori A Ashworth, Richard J Grand, Anthony L Meyer, Monica M McNeal, Matt C Gregas, Sandra K Burchett, Athos Bousvaros

Author Affiliations

1: Division of Gastroenterology, Hepatology, and Nutrition, Inflammatory Bowel Disease Center, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

Articles citing this

Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol (2014) 1.19

Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr (2011) 1.14

Efficacy of the vaccination in inflammatory bowel disease. World J Gastroenterol (2013) 1.12

Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) (2010) 1.10

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One (2011) 1.00

Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis (2011) 0.99

Designs of two randomized, community-based trials to assess the impact of influenza immunization during pregnancy on respiratory illness among pregnant women and their infants and reproductive outcomes in rural Nepal. BMC Pregnancy Childbirth (2015) 0.89

An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease. BMC Gastroenterol (2011) 0.88

Vaccinations in paediatric rheumatology: an update on current developments. Curr Rheumatol Rep (2015) 0.87

An audit of influenza vaccination status in adults with inflammatory bowel disease. Can J Gastroenterol (2012) 0.87

Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy. J Pediatr Gastroenterol Nutr (2010) 0.86

Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.86

Insufficient knowledge of korean gastroenterologists regarding the vaccination of patients with inflammatory bowel disease. Gut Liver (2014) 0.84

Updates in vaccination: recommendations for adult inflammatory bowel disease patients. World J Gastroenterol (2015) 0.82

Vaccination strategies in patients with IBD. Nat Rev Gastroenterol Hepatol (2013) 0.81

Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants. J Crohns Colitis (2012) 0.81

Prospective surveillance study of acute respiratory infections, influenza-like illness and seasonal influenza vaccine in a cohort of juvenile idiopathic arthritis patients. Pediatr Rheumatol Online J (2013) 0.80

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations. J Infect Dis (2012) 0.80

Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus? Can J Gastroenterol (2010) 0.80

Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression. Gastroenterol Hepatol (N Y) (2012) 0.79

Immunization history of children with inflammatory bowel disease. Can J Gastroenterol (2013) 0.78

ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol (2017) 0.78

Preventing infective complications in inflammatory bowel disease. World J Gastroenterol (2014) 0.77

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old. J Infect Dis (2015) 0.77

Anti-tumor necrosis factor therapy and influenza: keeping it in perspective. Therap Adv Gastroenterol (2010) 0.77

Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease. World J Gastroenterol (2015) 0.76

Influenza vaccination coverage in children with inflammatory bowel disease. Influenza Other Respir Viruses (2014) 0.75

Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy. Gastroenterol Hepatol (N Y) (2014) 0.75

Effects of immunosuppressants on immune response to vaccine in inflammatory bowel disease. Chin Med J (Engl) (2015) 0.75

Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New? Dig Dis Sci (2016) 0.75

Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial. J Gastroenterol (2015) 0.75

Articles cited by this

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12

Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med (2001) 18.25

Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23

A simple index of Crohn's-disease activity. Lancet (1980) 11.12

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32

Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr (1991) 4.11

Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. J Pediatr Gastroenterol Nutr (2005) 2.96

Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis (2004) 2.52

Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol (1994) 2.43

Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J (2001) 1.90

Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol (2006) 1.79

Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol (2002) 1.77

Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr (2007) 1.74

Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 1.64

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA (2007) 1.52

Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. Arch Intern Med (2002) 1.43

Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease. Clin Gastroenterol Hepatol (2007) 1.26

Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med (1978) 1.26

Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics (2007) 1.15

Influenza in children with cancer. J Pediatr (1989) 1.14

Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol (1999) 1.07

Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine. J Pediatr Gastroenterol Nutr (1995) 1.06

Current therapy of inflammatory bowel disease in children. Paediatr Drugs (2006) 1.02

Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer (2005) 1.00

Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids. Chest (1996) 0.93

Anti-tetanus toxoid antibody synthesis after booster immunization in systemic lupus erythematosus. Comparison of the in vitro and in vivo responses. Arthritis Rheum (1980) 0.88

Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy. Pediatr Infect Dis J (2008) 0.87

Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev (2006) 0.84

Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum (1980) 0.81

Articles by these authors

The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol (2007) 6.19

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66

Reduced lopinavir exposure during pregnancy. AIDS (2006) 3.98

Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2013) 2.65

A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol (2012) 2.63

Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest (2004) 2.40

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth. AIDS (2009) 2.29

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS (2012) 2.19

Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies. Clin Infect Dis (2011) 2.12

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet (2003) 2.04

Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr (2005) 1.98

Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease. J Pediatr Gastroenterol Nutr (2013) 1.82

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2014) 1.81

Management of ingested magnets in children. J Pediatr Gastroenterol Nutr (2012) 1.78

Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr (2007) 1.74

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2013) 1.69

The burden of influenza in young children, 2004-2009. Pediatrics (2013) 1.68

Hepatocyte nuclear factor-1 alpha, GATA-4, and caudal related homeodomain protein Cdx2 interact functionally to modulate intestinal gene transcription. Implication for the developmental regulation of the sucrase-isomaltase gene. J Biol Chem (2002) 1.68

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332. J Infect Dis (2004) 1.67

Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics (2006) 1.67

Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One (2012) 1.66

Lopinavir exposure with an increased dose during pregnancy. J Acquir Immune Defic Syndr (2008) 1.65

Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr (2004) 1.60

Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2014) 1.57

Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. J Acquir Immune Defic Syndr (2011) 1.55

Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol (2004) 1.53

CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children. AIDS (2007) 1.53

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA (2007) 1.52

Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis (2006) 1.43

Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams. J Pediatr Surg (2009) 1.42

Predictors of depression in youth with Crohn disease. J Pediatr Gastroenterol Nutr (2014) 1.42

An i2b2-based, generalizable, open source, self-scaling chronic disease registry. J Am Med Inform Assoc (2012) 1.39

Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci (2002) 1.38

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV. Clin Infect Dis (2007) 1.37

Tacrolimus-associated eosinophilic gastroenterocolitis in pediatric liver transplant recipients: role of potential food allergies in pathogenesis. Pediatr Transplant (2006) 1.34

Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis (2006) 1.34

Lopinavir tablet pharmacokinetics with an increased dose during pregnancy. J Acquir Immune Defic Syndr (2010) 1.33

The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol (2006) 1.33

Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol (2006) 1.33

Electrical impedance myography in spinal muscular atrophy: a longitudinal study. Muscle Nerve (2012) 1.31

Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol (2003) 1.29

Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2009) 1.26

Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol (2002) 1.26

Atazanavir pharmacokinetics with and without tenofovir during pregnancy. J Acquir Immune Defic Syndr (2011) 1.24

Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr (2010) 1.24

Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study. Horm Res Paediatr (2011) 1.23

Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry (2007) 1.22

The role of interferons in rotavirus infections and protection. J Interferon Cytokine Res (2003) 1.19

Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis (2009) 1.18

Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis (2007) 1.17

A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers. Am J Epidemiol (2012) 1.17

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis (2008) 1.17

Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy. Clin Infect Dis (2004) 1.17

Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol (2011) 1.16

Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study. JAMA Pediatr (2013) 1.15

Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr (2009) 1.15

Outcome following infliximab therapy in children with ulcerative colitis. Am J Gastroenterol (2010) 1.14

Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. J Acquir Immune Defic Syndr (2005) 1.14

Bone mineral density in children and adolescents with perinatal HIV infection. AIDS (2013) 1.13

Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis (2009) 1.13

A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis (2005) 1.13

Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score. Inflamm Bowel Dis (2010) 1.11

Pediatric inflammatory bowel disease: what children can teach adults. Inflamm Bowel Dis (2005) 1.11

Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics (2007) 1.10

IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PLoS One (2013) 1.09

Complex regulation of the lactase-phlorizin hydrolase promoter by GATA-4. Am J Physiol Gastrointest Liver Physiol (2004) 1.08

Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2011) 1.06

Physical interaction between GATA-5 and hepatocyte nuclear factor-1alpha results in synergistic activation of the human lactase-phlorizin hydrolase promoter. J Biol Chem (2002) 1.05

Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). J Virol (2007) 1.04

Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice. Protein Expr Purif (2004) 1.03

Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.03

Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals. J Acquir Immune Defic Syndr (2012) 1.03

Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response. J Infect Dis (2005) 1.02

Current therapy of inflammatory bowel disease in children. Paediatr Drugs (2006) 1.02

GATA4 mediates gene repression in the mature mouse small intestine through interactions with friend of GATA (FOG) cofactors. Dev Biol (2008) 1.02

Association of linear growth impairment in pediatric Crohn's disease and a known height locus: a pilot study. Ann Hum Genet (2010) 1.01

Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol (2004) 1.00

Factors that determine risk for surgery in pediatric patients with Crohn's disease. Clin Gastroenterol Hepatol (2010) 1.00

Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis. Oncology (2011) 0.99

Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr (2007) 0.99

5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Inflamm Bowel Dis (2006) 0.99

Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine (2002) 0.98

Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis (2006) 0.98

Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis (2009) 0.97

T-cell activation and neurodevelopmental outcomes in perinatally HIV-infected children. AIDS (2012) 0.97

Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates. J Virol (2006) 0.97

Gata4 and Hnf1alpha are partially required for the expression of specific intestinal genes during development. Am J Physiol Gastrointest Liver Physiol (2007) 0.96

Persistent rotavirus vaccine shedding in a new case of severe combined immunodeficiency: A reason to screen. J Allergy Clin Immunol (2010) 0.95

Impact of pregnancy on abacavir pharmacokinetics. AIDS (2006) 0.95

Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment. AIDS (2013) 0.95

Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents. Clin Immunol (2011) 0.94

Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus. Circulation (2013) 0.94

Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis. Inflamm Bowel Dis (2010) 0.94

Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One (2013) 0.93

Etiology and seasonality of viral respiratory infections in rural Honduran children. Pediatr Infect Dis J (2012) 0.93

Characterization of fast and slow diffusion from diffusion-weighted MRI of pediatric Crohn's disease. J Magn Reson Imaging (2012) 0.93

The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant. Vaccine (2002) 0.92